FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology
JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE(2023)
Abstract
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
MoreTranslated text
Key words
clinical trial diversity,clinical trial,pharmacoepidemiology
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined